paraneoplastic dermatomyositis
GPTKB entity
Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
autoimmune disease paraneoplastic syndrome |
| gptkbp:associatedWith |
gptkb:dermatomyositis
malignancy |
| gptkbp:complication |
myocarditis
dysphagia interstitial lung disease |
| gptkbp:diagnosedBy |
gptkb:EMG
MRI muscle biopsy autoantibody testing |
| gptkbp:firstDescribed |
20th century
|
| gptkbp:hasEpidemiology |
more common in women
more common in adults |
| https://www.w3.org/2000/01/rdf-schema#label |
paraneoplastic dermatomyositis
|
| gptkbp:prognosis |
prognosis depends on underlying cancer
|
| gptkbp:riskFactor |
gptkb:cancer
older age |
| gptkbp:symptom |
gptkb:Gottron's_papules
muscle weakness skin rash heliotrope rash |
| gptkbp:treatment |
gptkb:cancer
gptkb:methotrexate gptkb:IVIG immunosuppressive therapy corticosteroids |
| gptkbp:bfsParent |
gptkb:dermatomyositis
|
| gptkbp:bfsLayer |
5
|